CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SEELOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,282
-60.9%
99,356
+153.8%
0.00%
Q2 2023$46,782
+72.9%
39,1480.0%0.00%
Q1 2023$27,059
+1.8%
39,1480.0%0.00%
Q4 2022$26,581
-35.2%
39,1480.0%0.00%
Q3 2022$41,000
+51.9%
39,1480.0%0.00%
Q2 2022$27,000
-87.8%
39,148
-85.2%
0.00%
Q1 2022$222,000
-44.6%
264,684
+7.7%
0.00%
Q4 2021$401,000
-32.4%
245,6790.0%0.00%
Q3 2021$593,000
+12.3%
245,679
+22.9%
0.00%
Q2 2021$528,000
+329.3%
199,917
+714.3%
0.00%
Q1 2021$123,00024,5520.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 164,778$361,0000.48%
Uniplan Investment Counsel, Inc. 692,623$1,516,0000.10%
ARDSLEY ADVISORY PARTNERS LP 50,000$110,0000.02%
A.R.T. Advisors, LLC 52,342$115,0000.01%
WEDBUSH SECURITIES INC 16,000$35,0000.00%
WealthPLAN Partners, LLC 10,000$17,0000.00%
Renaissance Technologies 929,465$2,036,0000.00%
Squarepoint Ops LLC 28,629$63,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 17$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders